NCT06570291View on ClinicalTrials.gov

Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis

PHASE3RecruitingINTERVENTIONAL
Enrollment

520

Participants

Timeline

Start Date

February 28, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2028

Conditions
Knee Osteoarthritis
Interventions
DRUG

Mesenchymal Stem Cells

Allogenic adipose tissue-derived mesenchymal stem cells administrated for intra- articular use

DRUG

Sodium Hyaluronate Injection

Sodium Hyaluronate administrated for intra-articular use

Trial Locations (2)

Unknown

RECRUITING

RenJi Hospital, Shanghai

NOT_YET_RECRUITING

Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai

All Listed Sponsors
lead

Wuxi Cellular Biopharmaceutical Group Ltd.

INDUSTRY